The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial

The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial

The aim of the HYLAN M study was to investigate if symptoms and/or signs of patients suffering from severe dry eye disease (DED) can be improved by substituting individually optimized artificial tear therapy by high molecular weight hyaluronan (HMWHA) eye drops. In this international, multicenter st...

Full description

Bibliographic Details
Main Authors: Gysbert-Botho van Setten, Christophe Baudouin, Jutta Horwath-Winter, Daniel Böhringer, Oliver Stachs, Ebru Toker, Sultan Al-Zaaidi, Jose M. Benitez-del-Castillo, Ria Beck, Osama Al-Sheikh, Berthold Seitz, Stefano Barabino, Herbert A. Reitsamer, Wolfgang G.K. Müller-Lierheim
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Clinical Medicine
Subjects:
dry eye disease
severe keratitis
hyaluronan
hylan A
multicenter
randomized trial
Online Access:https://www.mdpi.com/2077-0383/9/11/3536

Internet

https://www.mdpi.com/2077-0383/9/11/3536

Similar Items